首页> 外国专利> Percutaneous administration containing fentanyl matrix type patch

Percutaneous administration containing fentanyl matrix type patch

机译:含芬太尼基质型贴剂的经皮给药

摘要

PROBLEM TO BE SOLVED: To obtain a newly prepared fentanyl-containing percutaneously absorbable administration matrix type patch including fentanyl or a salt thereof, having easiness for administration and control of adjustment of dosage and also, short percutaneous absorption delay time (time for cutaneous permeation rate to reach its steady state) (within 4 h) and capable of stably maintaining its effects by keeping stable blood concentrations. ;SOLUTION: This fentanyl-containing percutaneous absorbable administration matrix type patch is obtained by including fentanyl or a salt thereof in a tacky base consisting of a hydrophobic tack agent, a hydrophilic tack agent and N-methyl-2-pyrrolidone. This patch exhibits the percutaneously absorbable delay time for the drug of within 4 h. In the patch, fentanyl or a salt thereof is compounded at 1-10 wt.%; the hydrophobic tack agent at 10-50 wt.%; the hydrophilic tack agent at 5-30 wt.%; and N-methyl-2-pyrrolidone at 2-10 wt.%.;COPYRIGHT: (C)2000,JPO
机译:解决的问题:获得新制备的含有芬太尼或其盐的含芬太尼的经皮可吸收的给药基质型贴剂,其易于给药和控制剂量的调节,并且经皮吸收延迟时间(皮肤渗透率的时间短)短。 (在4小时内)达到稳定状态,并能够通过保持稳定的血液浓度来稳定地维持其效果。 ;解决方案:这种含芬太尼的经皮可吸收给药基质型贴剂是通过在由疏水性增粘剂,亲水性增粘剂和N-甲基-2-吡咯烷酮组成的粘性基质中加入芬太尼或其盐而制得的。该贴剂对药物的经皮吸收延迟时间为4小时。在贴剂中,以1-10wt。%的比例混合芬太尼或其盐。疏水增粘剂为10-50wt。%;亲水性增粘剂为5-30重量%;以及2-10 wt。%的N-甲基-2-吡咯烷酮;版权所有:(C)2000,JPO

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号